Combining nanoscale magnetic nimodipine liposomes with magnetic resonance image for Parkinson's disease targeting therapy.
Nanomedicine (Lond)
; 12(3): 237-253, 2017 Feb.
Article
en En
| MEDLINE
| ID: mdl-28093036
ABSTRACT
AIM:
To enhance drug targeting and blood-brain barrier penetration for Parkinson's disease (PD), a novel nanoscale magnetic nimodipine (NMD) delivery system was designed and prepared. MATERIALS &METHODS:
The PD rats were established and treated with free NMD or Fe3O4-modified NMD liposomes (Fe3O4-NMD-lips). Then, factional anisotropy values were measured by MRI to evaluate therapy efficacy.RESULTS:
Fe3O4-NMD-lips showed the best neuroprotective effect, and the NMD concentration of lesions was 2.5-fold higher in Fe3O4-NMD-lips group than that of free NMD group.CONCLUSION:
These results demonstrated that the magnetic drug system had a great potential to cross the blood-brain barrier and provided a noninvasive and effective therapeutic strategy for PD.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Métodos Terapéuticos y Terapias MTCI:
Terapias_biologicas
/
Aromoterapia
Asunto principal:
Enfermedad de Parkinson
/
Nimodipina
/
Fármacos Neuroprotectores
/
Nanopartículas de Magnetita
/
Liposomas
Idioma:
En
Revista:
Nanomedicine (Lond)
Año:
2017
Tipo del documento:
Article